Opko Health Stock Probability Of Bankruptcy

OPK Stock

USD 1.47 0.01 0.68%

Opko Health's chance of distress is below 50% at the moment. It has small odds of experiencing financial trouble in the next few years. Odds of financial distress prediction helps decision makers evaluate Opko Health's chance of financial distress in relation to its going-concern outlook and evaluation. All items used in analyzing the odds of distress are taken from the Opko balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Opko Health Piotroski F Score and Opko Health Altman Z Score analysis.

For more information on how to buy Opko Stock please use our How to buy in Opko Stock guide.

Market Cap is expected to rise to about 1.4 B this year. Enterprise Value is expected to rise to about 1.5 B this year

Opko Health Company odds of financial distress Analysis

Opko Health's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.

Probability Of Bankruptcy

Normalized

Z-Score

More About Probability Of Bankruptcy | All Equity Analysis

Current Opko Health Probability Of Bankruptcy

Less than 41%

Most of Opko Health's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Opko Health is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Our calculation of Opko Health probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting Opko Health odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of Opko Health financial health.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Opko Health. If investors know Opko will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Opko Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

0.191

Earnings Share

(0.19)

Revenue Per Share

0.998

Quarterly Revenue Growth

(0.03)

Return On Assets

(0.09)

The market value of Opko Health is measured differently than its book value, which is the value of Opko that is recorded on the company's balance sheet. Investors also form their own opinion of Opko Health's value that differs from its market value or its book value, called intrinsic value, which is Opko Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Opko Health's market value can be influenced by many factors that don't directly affect Opko Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Intangible Assets	Short Term Debt	Common Stock	Treasury Stock	Property Plant Equipment	Current Deferred Revenue	Long Term Debt	Short Term Investments	Net Receivables	Good Will	Net Tangible Assets	Capital Surpluse	Long Term Investments	Short Long Term Debt	Long Term Debt Total	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		1.0	0.19	-0.67	0.86	0.98	0.75	0.89	0.55	0.78	0.66	0.9	0.71	0.67	-0.53	0.85	0.95	0.26	0.91	0.59	0.4	0.41	-0.28	0.28	0.34
Total Stockholder Equity	1.0		0.14	-0.65	0.85	0.96	0.74	0.89	0.53	0.76	0.67	0.9	0.75	0.62	-0.51	0.86	0.95	0.24	0.91	0.62	0.4	0.39	-0.27	0.27	0.31
Net Debt	0.19	0.14		-0.72	0.48	0.31	0.01	-0.03	0.66	0.64	0.34	0.37	-0.21	0.73	-0.13	0.06	0.16	0.79	0.4	-0.36	0.38	0.69	-0.39	0.3	0.8
Retained Earnings	-0.67	-0.65	-0.72		-0.81	-0.71	-0.51	-0.44	-0.91	-0.94	-0.62	-0.79	-0.26	-0.85	0.46	-0.55	-0.67	-0.81	-0.85	0.01	-0.7	-0.87	0.5	-0.49	-0.83
Accounts Payable	0.86	0.85	0.48	-0.81		0.88	0.73	0.65	0.68	0.84	0.69	0.94	0.46	0.69	-0.41	0.86	0.84	0.59	0.89	0.2	0.46	0.67	-0.47	0.48	0.57
Total Liab	0.98	0.96	0.31	-0.71	0.88		0.73	0.88	0.57	0.81	0.62	0.89	0.6	0.76	-0.55	0.81	0.91	0.31	0.9	0.52	0.38	0.48	-0.31	0.31	0.39
Total Current Assets	0.75	0.74	0.01	-0.51	0.73	0.73		0.7	0.32	0.53	0.49	0.66	0.31	0.43	-0.42	0.89	0.7	0.26	0.74	0.24	0.22	0.49	-0.62	0.7	0.24
Intangible Assets	0.89	0.89	-0.03	-0.44	0.65	0.88	0.7		0.26	0.53	0.53	0.73	0.66	0.52	-0.5	0.77	0.89	-0.07	0.79	0.66	0.22	0.28	-0.08	0.1	0.07
Short Term Debt	0.55	0.53	0.66	-0.91	0.68	0.57	0.32	0.26		0.89	0.49	0.67	0.28	0.76	-0.42	0.39	0.53	0.79	0.71	-0.03	0.86	0.74	-0.4	0.38	0.83
Common Stock	0.78	0.76	0.64	-0.94	0.84	0.81	0.53	0.53	0.89		0.52	0.8	0.4	0.85	-0.62	0.58	0.72	0.72	0.85	0.17	0.61	0.7	-0.47	0.43	0.78
Treasury Stock	0.66	0.67	0.34	-0.62	0.69	0.62	0.49	0.53	0.49	0.52		0.75	0.45	0.5	0.14	0.64	0.7	0.44	0.76	0.18	0.47	0.54	-0.32	0.33	0.43
Property Plant Equipment	0.9	0.9	0.37	-0.79	0.94	0.89	0.66	0.73	0.67	0.8	0.75		0.6	0.69	-0.42	0.85	0.93	0.48	0.92	0.33	0.51	0.63	-0.29	0.3	0.47
Current Deferred Revenue	0.71	0.75	-0.21	-0.26	0.46	0.6	0.31	0.66	0.28	0.4	0.45	0.6		0.15	-0.3	0.52	0.77	-0.09	0.59	0.76	0.37	-0.03	0.22	-0.27	0.07
Long Term Debt	0.67	0.62	0.73	-0.85	0.69	0.76	0.43	0.52	0.76	0.85	0.5	0.69	0.15		-0.44	0.43	0.59	0.62	0.76	0.12	0.52	0.73	-0.39	0.37	0.68
Short Term Investments	-0.53	-0.51	-0.13	0.46	-0.41	-0.55	-0.42	-0.5	-0.42	-0.62	0.14	-0.42	-0.3	-0.44		-0.38	-0.47	-0.11	-0.45	-0.37	-0.21	-0.23	0.14	-0.14	-0.2
Net Receivables	0.85	0.86	0.06	-0.55	0.86	0.81	0.89	0.77	0.39	0.58	0.64	0.85	0.52	0.43	-0.38		0.85	0.28	0.82	0.35	0.3	0.46	-0.37	0.46	0.22
Good Will	0.95	0.95	0.16	-0.67	0.84	0.91	0.7	0.89	0.53	0.72	0.7	0.93	0.77	0.59	-0.47	0.85		0.26	0.94	0.56	0.47	0.5	-0.15	0.17	0.35
Net Tangible Assets	0.26	0.24	0.79	-0.81	0.59	0.31	0.26	-0.07	0.79	0.72	0.44	0.48	-0.09	0.62	-0.11	0.28	0.26		0.51	-0.44	0.55	0.8	-0.58	0.56	0.92
Capital Surpluse	0.91	0.91	0.4	-0.85	0.89	0.9	0.74	0.79	0.71	0.85	0.76	0.92	0.59	0.76	-0.45	0.82	0.94	0.51		0.34	0.6	0.72	-0.39	0.4	0.6
Long Term Investments	0.59	0.62	-0.36	0.01	0.2	0.52	0.24	0.66	-0.03	0.17	0.18	0.33	0.76	0.12	-0.37	0.35	0.56	-0.44	0.34		0.02	-0.32	0.37	-0.34	-0.29
Short Long Term Debt	0.4	0.4	0.38	-0.7	0.46	0.38	0.22	0.22	0.86	0.61	0.47	0.51	0.37	0.52	-0.21	0.3	0.47	0.55	0.6	0.02		0.62	-0.16	0.18	0.64
Long Term Debt Total	0.41	0.39	0.69	-0.87	0.67	0.48	0.49	0.28	0.74	0.7	0.54	0.63	-0.03	0.73	-0.23	0.46	0.5	0.8	0.72	-0.32	0.62		-0.53	0.56	0.81
Net Invested Capital	-0.28	-0.27	-0.39	0.5	-0.47	-0.31	-0.62	-0.08	-0.4	-0.47	-0.32	-0.29	0.22	-0.39	0.14	-0.37	-0.15	-0.58	-0.39	0.37	-0.16	-0.53		-0.95	-0.48
Net Working Capital	0.28	0.27	0.3	-0.49	0.48	0.31	0.7	0.1	0.38	0.43	0.33	0.3	-0.27	0.37	-0.14	0.46	0.17	0.56	0.4	-0.34	0.18	0.56	-0.95		0.42
Capital Stock	0.34	0.31	0.8	-0.83	0.57	0.39	0.24	0.07	0.83	0.78	0.43	0.47	0.07	0.68	-0.2	0.22	0.35	0.92	0.6	-0.29	0.64	0.81	-0.48	0.42

	2020	2021	2022	2023	2024	2025 (projected)
Return On Assets	0.0124	(0.0123)	(0.15)	(0.0939)	(0.0845)	(0.0887)
Asset Turnover	0.39	0.58	0.74	0.46	0.43	0.41
Net Debt	149.8M	53.2M	60.3M	230.7M	265.3M	278.5M
Total Current Liabilities	375.5M	301.8M	213.5M	200.1M	230.1M	241.6M
Non Current Liabilities Total	426M	412.8M	392.2M	422.4M	485.8M	510.1M
Total Assets	2.5B	2.4B	2.2B	2.0B	2.3B	2.4B
Total Current Assets	523.2M	823M	394.5M	309.5M	355.9M	183.8M
Total Cash From Operating Activities	39.5M	38.3M	(95.2M)	(28.2M)	(25.4M)	(26.6M)

	Return On Equity	-0.0939
	Return On Asset	-0.0897
	Profit Margin	(0.19) %
	Operating Margin	(0.62) %
	Current Valuation	1.09 B
	Shares Outstanding	672.8 M
	Shares Owned By Insiders	54.48 %
	Shares Owned By Institutions	27.79 %
	Number Of Shares Shorted	91.33 M
	Price To Earning	7.46 X
	Price To Book	0.70 X
	Price To Sales	1.39 X
	Revenue	863.5 M
	Gross Profit	84.38 M
	EBITDA	(65.52 M)
	Net Income	(188.86 M)
	Cash And Equivalents	210.46 M
	Cash Per Share	0.27 X
	Total Debt	326.56 M
	Debt To Equity	0.16 %
	Current Ratio	2.30 X
	Book Value Per Share	2.06 X
	Cash Flow From Operations	(28.2 M)
	Short Ratio	21.67 X
	Earnings Per Share	(0.19) X
	Price To Earnings To Growth	(2.87) X
	Target Price	3.96
	Number Of Employees	3.93 K
	Beta	1.65
	Market Capitalization	989.02 M
	Total Asset	2.01 B
	Retained Earnings	(2.01 B)
	Working Capital	109.42 M
	Current Asset	454.06 M
	Current Liabilities	251.9 M
	Net Asset	2.01 B

Opko Health Stock Probability Of Bankruptcy

Opko Health Company odds of financial distress Analysis

Probability Of Bankruptcy

Normalized

Z-Score

Current Opko Health Probability Of Bankruptcy

Opko Probability Of Bankruptcy Driver Correlations

Opko Probability Of Bankruptcy Peer Comparison

Opko Health Main Bankruptcy Drivers

Opko Fundamentals

About Opko Health Fundamental Analysis

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY